Skip to: content – navigation

2017 Scientific Program

Submitted by Jennifer Burges... on Mon, 05/15/2017 - 18:09

Name of Meeting: 

2017 Scientific Program

Resources of the event: 

Effective Interaction with the Government Regarding Cancer Drug Access_The Hon John Brumby AO

Cancer Drugs Alliance (CDA) involvement_Prof John Zalcberg OAM

Clinical Benefit Parameters (ASCO, ESMO)_Prof Andrew Wilson

TGA Reform_Dr Larry Kelly

Premium Sponsor Address_Ms Tracey Padman, Roche Products

Premium Sponsor Address_Dr Ian Irving, Icon Cancer Care

Status of Oncology Clinical Committee/Taskforce Review_A/Prof Mustafa Khasraw

Potential Impact of MBS Review for Private Oncology_Dr Ian Irving

Lobby activities by PCPA/Stakeholder Group_Ms Jannette Cotterell

Appropriate Prescribing of Chemotherapy - the Role of eviQ Guidelines_A/Prof Jeremy Shapiro

Chaired Panel Discussion: A/Prof Chris Karapetis, A/Prof Jeremy Shapiro and Dr Owen Bradfield

read more
read more
Physicians
Strong leadership group
The PCPA has significant strengths which provide a strong foundation for future development.
read more
Join the PCPA
Enjoy all the benefits of membership
With a strong leadership group and a potential membership base of all private oncologists and haematologists, PCPA represents a critical group of specialists in the cancer care service spectrum.
join PCPA
Become a Sponsor
We offer our members professional support and more
The PCPA offers its members professional support, networking opportunities, a forum for the exchange of knowledge and an opportunity to be part of the decision making process to help shape the future of private cancer medicine in Australia.
read more